These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 3071139

  • 1. Captopril-induced metabolic acidosis with hyperkalemia.
    Sakemi T, Ohchi N, Sanai T, Rikitake O, Maeda T.
    Am J Nephrol; 1988; 8(3):245-8. PubMed ID: 3071139
    [Abstract] [Full Text] [Related]

  • 2. Interaction of minoxidil and captopril in the treatment of refractory hypertension.
    Matson JR, Norby LH, Robillard JE.
    Am J Dis Child; 1981 Mar; 135(3):256-8. PubMed ID: 7010994
    [Abstract] [Full Text] [Related]

  • 3. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
    Kee CS, Choi JW, Chang DK, Ahn YH, Kim HJ.
    J Korean Med Sci; 1993 Dec; 8(6):464-70. PubMed ID: 8179835
    [Abstract] [Full Text] [Related]

  • 4. Primary role of hyperkalemia in the acidosis of hyporeninemic hypoaldosteronism.
    Matsuda O, Nonoguchi H, Tomita K, Shiigai T, Ida T, Shinohara S, Ideura T, Takeuchi J.
    Nephron; 1988 Dec; 49(3):203-9. PubMed ID: 3398981
    [Abstract] [Full Text] [Related]

  • 5. Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
    Nahum H, Paillard M, Prigent A, Leviel F, Bichara M, Gardin JP, Idatte JM.
    Am J Nephrol; 1986 Dec; 6(4):253-62. PubMed ID: 3777034
    [Abstract] [Full Text] [Related]

  • 6. Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure.
    Zanella MT, Mattei E, Draibe SA, Kater CE, Ajzen H.
    Clin Pharmacol Ther; 1985 Dec; 38(6):613-7. PubMed ID: 2998675
    [Abstract] [Full Text] [Related]

  • 7. [A case of lupus nephritis with hyporeninemic hypoaldosteronism].
    Wada J, Makino H, Ota Z, Yokoi T, Nagayama K, Asano K, Fukushima M.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):817-24. PubMed ID: 1770640
    [Abstract] [Full Text] [Related]

  • 8. [Hyperkalemic, hyperchloremic acidosis in moderate chronic renal insufficiency and selective hypoaldosteronism].
    Caron C, Nawar T, Montambault P, Plante GE, Kandalaft N.
    Union Med Can; 1977 Dec; 106(12):1640-4. PubMed ID: 601918
    [No Abstract] [Full Text] [Related]

  • 9. Hyperchloremic metabolic acidosis due to deferasirox in a patient with beta thalassemia major.
    Papadopoulos N, Vasiliki A, Aloizos G, Tapinis P, Kikilas A.
    Ann Pharmacother; 2010 Jan; 44(1):219-21. PubMed ID: 19934389
    [Abstract] [Full Text] [Related]

  • 10. Hyperkalemia in type 4 renal tubular acidosis associated with systemic lupus erythematosus.
    Üsküdar Cansu D, Cansu GB, Güvenir S, Korkmaz C.
    Rheumatol Int; 2020 Nov; 40(11):1895-1901. PubMed ID: 32166438
    [Abstract] [Full Text] [Related]

  • 11. Hyporeninemic hypoaldosteronism after renal transplantation.
    Perez GO, Oster JR.
    South Med J; 1977 Mar; 70(3):363-4. PubMed ID: 322303
    [Abstract] [Full Text] [Related]

  • 12. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T, Saito T, Miyai I, Nozaki S, Kang J.
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of renal hyperchloremic acidosis resulting from dietary potassium restriction in the dog: role of aldosterone.
    Hulter HN, Sebastian A, Sigala JF, Licht JH, Glynn RD, Schambelan M, Biglieri EG.
    Am J Physiol; 1980 Feb; 238(2):F79-91. PubMed ID: 7361893
    [Abstract] [Full Text] [Related]

  • 14. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P.
    Schweiz Med Wochenschr; 1982 Dec 04; 112(49):1764-74. PubMed ID: 6758113
    [Abstract] [Full Text] [Related]

  • 15. Familial hyperkalemia, hypertension, and hyporeninemia with normal aldosterone levels. A tubular defect in potassium handling.
    Brautbar N, Levi J, Rosler A, Leitesdorf E, Djaldeti M, Epstein M, Kleeman CR.
    Arch Intern Med; 1978 Apr 04; 138(4):607-10. PubMed ID: 637641
    [Abstract] [Full Text] [Related]

  • 16. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
    Burnakis TG, Mioduch HJ.
    Arch Intern Med; 1984 Dec 04; 144(12):2371-2. PubMed ID: 6391404
    [Abstract] [Full Text] [Related]

  • 17. Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies.
    Batlle D, Itsarayoungyuen K, Arruda JA, Kurtzman NA.
    Am J Med; 1982 Feb 04; 72(2):188-92. PubMed ID: 7036725
    [Abstract] [Full Text] [Related]

  • 18. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism.
    Tan SY, Shapiro R, Franco R, Stockard H, Mulrow PJ.
    Ann Intern Med; 1979 May 04; 90(5):783-5. PubMed ID: 434681
    [Abstract] [Full Text] [Related]

  • 19. Classification of pseudohypoaldosteronism type II as type IV renal tubular acidosis: results of a literature review.
    Adachi M, Motegi S, Nagahara K, Ochi A, Toyoda J, Mizuno K.
    Endocr J; 2023 Jul 28; 70(7):723-729. PubMed ID: 37081692
    [Abstract] [Full Text] [Related]

  • 20. Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practice.
    Ruiz-Sánchez JG, Calle-Pascual AL, Rubio-Herrera MÁ, De Miguel Novoa MP, Gómez-Hoyos E, Runkle I.
    Front Endocrinol (Lausanne); 2022 Jul 28; 13():990148. PubMed ID: 36303866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.